Directors and Officers Underwriting for SEBI-Listed Companies in 2026: Sides A, B, C, ABL, IPO POSI

The Indian D&O market for SEBI-listed companies has moved through three distinct phases since 2020. The 2020 to 2022 phase was a soft market with capacity growth, declining rates, and broadening cover. The 2023 phase saw a turn driven by an emerging cluster of NCLT and SEBI enforcement actions, with rate stabilisation and selective tightening on regulated-sector accounts. The 2024 to 2026 phase has been a hardening market, with broker-reported rate increases broadly in the range of 15 to 35 percent on many mid-cap and large-cap listed company D&O placements, capacity reductions on the most exposed accounts, and policy wording tightening across the Indian market. These ranges are indicative of market experience rather than published tariff rates: D&O is a fully de-tariffed line, so the actual outcome on any account turns on its own size, sector, governance, and claims history.

The drivers of the 2024 to 2026 hardening sit in four areas. First, the volume and severity of SEBI enforcement orders against directors and key managerial personnel under the SEBI (Prohibition of Insider Trading) Regulations 2015 and the SEBI (LODR) Regulations 2015 has continued rising, with several high-profile orders against independent directors in addition to the executive directors who were the historical focus. Second, the NCLT and NCLAT exposure on directors of companies entering CIRP under the Insolvency and Bankruptcy Code 2016 has produced a steady stream of personal proceedings against directors for alleged wrongful trading, related-party transactions, and breach of fiduciary duty. Third, the shareholder activism in Indian listed companies has increased with formal and informal challenges against board decisions, executive compensation, and corporate transactions. Fourth, the class action mechanism under Section 245 of the Companies Act 2013, while still infrequently used in practice, has begun to produce filings that affect the underwriter's view of mid-cap and large-cap D&O exposure.

The Indian listed company D&O market is now operating with materially different terms than the 2020 to 2022 baseline. The placement conversation has moved from a transactional renewal to a structured underwriting dialogue covering Side A, B, and C limits, Additional Side A Limit (ABL) for non-executive directors, exclusion language, retention structures, claims-made trigger dynamics, and the specific cover for IPO and follow-on offering exposure.

This guide lays out the 2026 underwriting framework for SEBI-listed D&O. It covers Sides A, B, and C; ABL for non-executive directors; IPO POSI cover; common exclusions; pricing benchmarks for mid-cap and large-cap; and the recent NCLT, NCLAT, and SEBI order exposure that is shaping the market.

D&O policies for SEBI-listed entities are structured around three coverage triggers (Sides) that respond to different financial loss scenarios. Understanding which Side responds to which loss is essential to programme design and to negotiating limits and retentions.

Side A: Direct cover for individual directors and officers

Side A responds when an individual director or officer suffers loss that is not indemnified by the company. The most common Side A scenarios are: insolvency of the company removing the indemnification balance sheet, statutory prohibition on company indemnification (the SEBI Act and the Companies Act both contain provisions limiting company indemnification for certain types of liability), denial of indemnification by the company board, and shareholder-derivative actions where the company cannot indemnify the defendant directors on whose conduct the action turns.

Side A is the most important Side for non-executive directors. NEDs typically rely on Side A as the primary protection because the company indemnification balance sheet may not be available to them in scenarios where the company itself is a respondent or in the proceeding. The Side A limit and the retention structure should reflect the NED's specific exposure rather than mirroring the executive director treatment.

Side B: Company reimbursement for indemnification

Side B responds when the company indemnifies a director or officer for loss arising from the director's role and the policy reimburses the company. Side B is the company's recovery mechanism for its own indemnification spending, including legal defence costs, settlement amounts, and judgement satisfaction.

Side B is the financially largest component of most listed company D&O programmes because most claims are resolved through company indemnification with subsequent insurance recovery rather than through direct payment to individual directors. The Side B retention is typically the dominant retention in the placement structure.

Side C: Entity securities cover

Side C responds to securities claims against the company itself. The trigger is a securities claim, defined as a claim alleging violation of securities laws or regulations affecting the company's securities. Side C cover is more contested in the Indian market than in the US market because the Indian securities class action mechanism (Section 245 of the Companies Act 2013 read with Rule 84 of the NCLT Rules 2016) remains less actively used than the US Rule 23(b)(3) class action. However, the Indian regulatory environment produces equivalent exposure through SEBI enforcement orders, exchange disciplinary proceedings, and individual shareholder claims under the Companies Act.

The 2026 listed company D&O placements typically include Side C with limits below the Side A and B limits, reflecting the lower expected severity of Indian securities claims relative to US benchmarks but the non-trivial expected frequency.

The aggregate limit structure

Most Indian listed company D&O placements use an aggregate policy limit across all three Sides rather than separate limits per Side. The aggregate structure means that a large Side C securities claim can exhaust the policy limit and leave reduced or no cover for subsequent Side A or B claims in the policy year. This dynamic drives the demand for ABL structures that ring-fence cover for non-executive directors against erosion by entity claims.

A minority of placements use separate limits per Side, with Side A having a ring-fenced limit that cannot be eroded by Side B or C claims. The separate-limit structure carries higher premium but provides cleaner protection for non-executive directors.

The Additional Side A Limit (ABL), also known as Independent Director Liability (IDL) or Excess Side A, is a separate policy layer that sits above the primary D&O programme and responds only to Side A loss. The ABL is the key 2026 placement consideration for non-executive directors of SEBI-listed companies, and its adoption has grown materially through the 2024 to 2026 cycle.

Why ABL matters for non-executive directors

Non-executive directors of SEBI-listed companies serve under the LODR 2015 requirements with personal exposure to SEBI enforcement, NCLT proceedings, shareholder actions, and statutory liability under multiple Indian regulations (Companies Act 2013, SEBI Act 1992, the Income Tax Act, GST, environmental laws, labour laws, sector-specific regulations). The personal exposure is real and not theoretical: the 2023 to 2025 period saw multiple SEBI orders against independent directors of listed companies including in the Yes Bank, DHFL, Coffee Day, and other matters.

The primary D&O programme provides cover for the non-executive director through Side A. However, the aggregate limit structure means that the Side A cover can be eroded by Side B and Side C claims. A large entity securities claim or a substantial company indemnification recovery can exhaust the policy limit, leaving the non-executive director without cover for a subsequent personal proceeding.

ABL ring-fences a dedicated limit for Side A only, protecting the non-executive director against erosion. The ABL layer responds only when the primary policy is exhausted or has been declined for the Side A claim, providing a guaranteed cover position for personal exposure.

ABL structure and limits

A typical ABL structure for a mid-cap SEBI-listed company in 2026 provides an ABL limit of INR 25 to 75 crore sitting above the primary D&O programme. For large-cap listed companies the ABL limit typically runs at INR 100 to 300 crore. For the largest Indian listed companies (Reliance, TCS, Infosys, HDFC Bank, Bharti Airtel, and similar) the ABL limit may exceed INR 500 crore through layered placements.

The ABL retention is typically zero or nominal because the structure is intended to provide unbroken protection for non-executive directors. The trigger is exhaustion or declination of the underlying programme, with the ABL responding directly to the non-executive director's claim without further insured-side payment.

Eligible insureds under ABL

The ABL coverage population typically includes independent directors, non-executive directors, and in some structures the audit committee members and nomination and remuneration committee members specifically. The eligible insured definition is a placement negotiation point, with the buyer seeking broad coverage of all non-executive directors and the underwriter sometimes restricting cover to specific categories.

Pricing benchmarks for ABL

ABL pricing depends on the underlying programme size, the company's exposure profile, the number of non-executive directors, and the company's claims history. Typical 2026 pricing for ABL on a mid-cap SEBI-listed company runs at 0.8 to 2.5 percent of the ABL limit annually. For large-cap companies the rate is lower at 0.4 to 1.5 percent reflecting the larger overall programme size and the spread of capacity.

ABL is increasingly the differentiator on listed company D&O placements in 2026. Buyers that approach the renewal cycle with the ABL structure clearly understood and the non-executive director protection adequately scaled experience better board governance outcomes than buyers treating D&O as a generic corporate cover.

Companies undertaking an Initial Public Offering or a major follow-on offering on Indian exchanges face a discrete exposure window that the standard D&O policy does not adequately cover. The Public Offering of Securities Insurance (POSI) is the specific cover designed for this window, and its placement has become standard practice for Indian IPO transactions above approximately INR 1,000 crore offering size.

The IPO exposure window

IPO exposure arises from disclosures in the offer documents (Draft Red Herring Prospectus, Red Herring Prospectus, and Prospectus) and from communications during the offering period. The exposure has three primary failure modes.

1. Misstatement or omission claims: claims alleging that the offer documents contained material misstatements or omitted material information, brought by investors who purchased in the offering.
2. SEBI enforcement: SEBI proceedings against the company, directors, and merchant bankers for alleged violations of the ICDR Regulations or other applicable securities regulations.
3. Civil and class actions: civil suits brought by investors under the Companies Act, the SEBI Act, or general civil law alleging losses arising from the offering disclosures.

The exposure window extends from the DRHP filing through the listing and into the post-listing period. The standard listed company D&O policy responds to the post-listing exposure but typically excludes the IPO-period exposure or covers it only at reduced limits. POSI is designed to fill the gap.

POSI structure

POSI is a discrete policy with a dedicated limit and a defined cover period (typically 6 years from the offering date, reflecting the statutory limitation periods for relevant claims). The cover responds to claims arising from the offer documents and the offering process, with insured parties including the company, directors and officers, the selling shareholders if applicable, the merchant bankers in some structures, and the underwriters in some structures.

POSI is structured separately from the company's ongoing D&O programme to avoid the IPO-period exposure eroding the ongoing programme limits. The POSI policy is typically placed at the time of the offering and runs for the 6-year period independently of the company's annual D&O renewals.

POSI limits and pricing

POSI limits for Indian IPOs typically run at 15 to 40 percent of the offering size as a starting reference, scaled by the underwriter's assessment of the disclosure quality, the sector, the regulatory exposure, and the company's pre-IPO governance maturity. An IPO of INR 5,000 crore typical offering size would carry POSI limit in the INR 750 to 2,000 crore range.

POSI pricing is determined as a one-time premium for the 6-year cover period, typically at 2 to 5 percent of the POSI limit. The pricing reflects the concentrated exposure during the 6-year window and the long-tail claim development pattern.

2024 to 2026 IPO POSI activity

The Indian IPO market through 2024 to 2026 has continued at high volume with multiple INR 5,000 crore plus offerings. POSI placements on the larger IPOs have become standard practice with the major Indian insurers competing alongside Lloyd's syndicates and international markets accessed through GIFT City structures. The market discipline on POSI has tightened in 2026 with underwriters requiring detailed pre-placement diligence on the offer document drafting process, the auditor and legal counsel quality, and the company's pre-IPO governance maturity.

For brokers placing POSI cover on Indian IPO transactions, the practical advice is to engage with the underwriters at the DRHP filing stage rather than waiting for the offering period. The pre-IPO underwriting dialogue allows the buyer to address risk improvement points (governance enhancements, audit committee strengthening, disclosure quality improvements) that improve placement terms by the time the offering closes.

Indian listed company D&O policies in 2026 carry a defined set of exclusions that shape the practical cover position. The exclusions have tightened progressively through the 2023 to 2026 hardening cycle, with the wording moves below being the most material for SEBI-listed buyers.

Fraud exclusion

The fraud exclusion excludes loss arising from the insured's intentional fraudulent conduct. The 2026 standard wording typically requires a final adjudication of fraud before the exclusion operates, with the policy providing defence cover through the proceedings and recovering paid amounts only on final adjudication. The final-adjudication structure is the cedant-favourable wording; some Indian placements still use the older formulation where the insurer can decline cover on its own assessment of fraud without waiting for final adjudication.

The distinction matters because fraud allegations in SEBI orders and NCLT proceedings frequently arise but rarely reach final adjudication for many years. The final-adjudication wording provides protection through the defence stage even where the allegations are eventually upheld.

Prior acts exclusion

The prior acts exclusion excludes loss arising from acts committed before the policy inception date or before a defined retroactive date. The wording is material at programme inception and at any change of insurer because gaps in retroactive coverage produce uninsured exposure for acts committed during the gap period.

The 2026 placement practice is to negotiate full prior acts cover (retroactive date matching the earliest D&O policy held by the insured) at programme inception and to maintain continuity through subsequent renewals. The insurer's appetite for full prior acts cover depends on the insured's claims history and the underwriting diligence at inception.

Insured versus insured exclusion

The insured versus insured exclusion excludes claims brought by one insured against another insured under the policy. The exclusion was historically broad and excluded shareholder-derivative actions where the company nominally is the claimant against its own directors. The 2026 standard wording typically carves out shareholder-derivative actions from the exclusion, recognising that derivative actions are a legitimate enforcement mechanism that the policy should respond to.

The exclusion still operates against direct claims by one director against another and against claims by the company against its own directors outside the derivative-action carve-out.

Regulatory exclusions

Indian D&O policies typically include exclusions for fines and penalties imposed by regulators (where statutory law makes them uninsurable as a matter of public policy) and for disgorgement of unjust gains. The exclusions are operative under Indian law for criminal fines and for regulatory disgorgement orders.

The 2026 wording typically covers defence costs and legal proceedings even for matters where the underlying fine or penalty would be excluded, recognising that the defence cost protection is the primary value of the cover in regulatory matters.

Bodily injury and property damage exclusions

Standard D&O wording excludes bodily injury and property damage, which fall under general liability or workers compensation rather than D&O. The exclusion is broadly worded to include consequential personal injury arising from the insured's conduct in their D&O role.

Pollution exclusions

Indian D&O policies typically exclude pollution-related claims, with carve-outs for shareholder-derivative actions arising from pollution events affecting the company's value. The carve-out is increasingly being negotiated as climate-related litigation against directors becomes a more concrete risk in the 2026 market.

Indian listed company D&O pricing in 2026 varies widely, with the actual placement outcome depending on company size, sector, regulatory profile, governance maturity, and claims history. The figures below are indicative market reference ranges drawn from broker placement experience, not published rates, and any specific account can fall outside them. They are offered to help buyers and brokers frame expectations, not as a quote.

Mid-cap SEBI-listed companies (market cap INR 5,000 to 25,000 crore)

Mid-cap listed companies typically place D&O programmes with limits in the INR 100 to 400 crore range across all Sides plus ABL of INR 25 to 75 crore. The primary D&O programme is typically structured with an aggregate limit, with retention at INR 25 lakh to INR 2 crore depending on the Side. The annual premium typically runs in the INR 35 lakh to INR 1.8 crore range for the primary programme plus INR 12 to 75 lakh for the ABL.

The sector matters within the mid-cap band. Financial services and pharmaceuticals mid-caps typically face higher rates than industrial or consumer goods mid-caps reflecting the higher regulatory exposure. IT services mid-caps typically face moderate rates with the offshore client class action exposure becoming more material in 2026 placements.

Large-cap SEBI-listed companies (market cap INR 25,000 to 1,00,000 crore)

Large-cap listed companies typically place D&O programmes with limits in the INR 400 to 1,500 crore range plus ABL of INR 100 to 300 crore. The primary placement structure typically involves a tower of primary, first excess, second excess, and additional excess layers with multiple insurers participating. The annual premium typically runs in the INR 1.5 to 8 crore range for the primary tower plus INR 50 lakh to INR 4 crore for the ABL.

Mega-cap SEBI-listed companies (market cap above INR 1,00,000 crore)

Mega-cap listed companies typically place D&O programmes with limits above INR 1,500 crore plus ABL above INR 300 crore. The placement involves multiple international markets including Lloyd's syndicates, US carriers, and European carriers, accessed through Indian brokers and GIFT City structures. The annual premium typically runs above INR 8 crore for the primary tower plus above INR 4 crore for the ABL.

Pricing drivers in 2026

Five drivers shape the 2026 placement outcome.

1. Company size and scale: larger companies face higher absolute premium but typically at lower rate-on-line, with the rate compressing as the placement spreads across more capacity providers.
2. Sector exposure: financial services, pharmaceuticals, real estate, infrastructure, and IT services typically face higher rates than industrial, consumer goods, or chemicals.
3. Regulatory profile: companies with active SEBI proceedings, NCLT exposure, ED or CBI investigations, or tax disputes face material loadings or outright declinations from some capacity providers.
4. Governance maturity: companies with strong board composition (high independent director ratio, qualified audit committee, separate roles of chairman and CEO, structured nomination and remuneration practices) face better placement terms.
5. Claims history: insureds with material prior D&O claims face higher rates and reduced capacity availability, with the impact persisting across multiple renewal cycles.

For brokers placing listed company D&O in 2026, the practical advice is to address each of these drivers explicitly in the placement submission, pre-empting the questions the underwriter would otherwise ask and evidencing the answers with board and committee documentation.

The 2023 to 2026 period has produced a steady flow of NCLT, NCLAT, and SEBI orders that have materially shaped the Indian listed company D&O market position. The cases below illustrate the exposure patterns rather than exhausting the list.

SEBI insider trading and disclosure orders

The SEBI Prohibition of Insider Trading Regulations 2015 framework has produced multiple orders against directors, key managerial personnel, and connected persons of listed companies through the 2023 to 2025 period. The orders typically combine monetary penalties (in the INR 25 lakh to INR 10 crore range per respondent), disgorgement of alleged unjust gains, and prohibition from accessing the securities market for specified periods.

The D&O exposure from SEBI orders is primarily the defence cost cover during the proceedings, the legal cost of appeals to the Securities Appellate Tribunal (SAT), and the indemnification of settlement amounts where the policy responds. The fraud-exclusion wording is the critical determinant of cover scope; final-adjudication wording provides cover through the defence stage even where the SEBI order is eventually upheld.

NCLT proceedings against directors of companies under CIRP

The Insolvency and Bankruptcy Code 2016 framework has produced sustained NCLT proceedings against directors of listed companies entering CIRP. The proceedings include avoidance actions under Sections 43, 45, 49, and 66 of the IBC against alleged preferential transactions, undervalued transactions, fraudulent transactions, and wrongful trading respectively. The NCLT and NCLAT have produced multiple orders against directors with personal liability for amounts in the INR 100 crore plus range.

The D&O exposure from CIRP proceedings is the personal defence cost cover and the indemnification of personal liability amounts where the policy responds. The CIRP exposure is the primary driver of Side A demand for non-executive directors of listed companies in distress sectors. Section 66 wrongful-trading liability is generally directed at directors and persons who were knowingly party to carrying on the business with intent to defraud creditors, so non-executive directors who were not involved in the relevant decisions are typically better placed to resist personal liability than executive directors. Even so, the cost and duration of defending such proceedings is itself a significant exposure, which keeps Side A protection central to non-executive director risk management.

Securities Appellate Tribunal appeals

SEBI orders are appealed to the SAT under Section 15T of the SEBI Act 1992. The SAT appeal process typically extends 12 to 36 months from order to final disposal, with the defence cost during the appeal a material component of the D&O claim cost. The 2026 placement practice is to confirm that the policy responds through the SAT appeal stage and into any subsequent Supreme Court appeal under Section 15Z.

Companies Act 2013 proceedings

The Companies Act 2013 framework produces NCLT proceedings under multiple sections including Sections 241 to 246 (oppression and mismanagement), Section 245 (class actions), Section 339 (fraudulent business conduct), and Section 447 (fraud penalty). The D&O exposure from these proceedings is the defence cost and the indemnification of liability amounts where the policy responds.

Income Tax and GST disputes

Director personal exposure under the Income Tax Act and the CGST Act for tax matters of the company has produced a growing claims component on Indian listed company D&O. The tax authorities have increasingly named directors in personal proceedings for alleged tax evasion, with the proceedings producing defence cost exposure even where the underlying matter is eventually resolved in the company's favour.

The 2026 market response

The Indian D&O market response to the recent order exposure includes the following moves.

1. Tighter underwriting diligence at placement, with detailed review of the insured's regulatory exposure, audit qualifications, related-party transaction disclosures, and pending proceedings.
2. Expanded use of pre-placement disclosure questionnaires covering recent legal developments, audit committee minutes, and board minutes on material matters.
3. Selective declines or restricted cover on companies with material pending proceedings or weak governance indicators.
4. Higher retention requirements on accounts with material claims history or active regulatory exposure.
5. ABL placement now standard for non-executive directors of mid-cap and large-cap listed companies, with the ABL structure ring-fencing protection against primary policy erosion.

For SEBI-listed buyers approaching the 2026 D&O renewal cycle, the practical advice is to invest in placement preparation. A submission that documents governance maturity, a clean claims history, careful regulatory disclosure, and a deliberate ABL structure gives underwriters the evidence they need to price favourably and to hold capacity. A thin submission that leaves the underwriter to assume the worst on regulatory exposure and governance tends to draw loadings, higher retentions, or reduced limits.